Imagery Rescripting and Imaginal Exposure for Social Anxiety: Mechanisms and Outcomes in an Analog Sample

Last updated: October 25, 2022
Sponsor: Hebrew University of Jerusalem
Overall Status: Active - Recruiting

Phase

N/A

Condition

Anxiety Disorders

Social Phobia

Social Anxiety Disorder (Sad)

Treatment

N/A

Clinical Study ID

NCT04635904
isf2157/2020
  • Ages 18-70
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This study will recruit 100 participants who self-report high symptoms of social anxiety (Social phobia inventory >30). Participants will be randomly assigned to receive either one analog intervention of Imagery Rescripting (IR) or Imaginal Exposure. We will test the efficacy and mechanisms behind each interventions.

Eligibility Criteria

Inclusion

Inclusion Criteria: SPIN scores >= 30 -

Exclusion

Exclusion Criteria: can't report a negative imagery related to a future social scenario. Attending activepsychotherapy sessions.

Study Design

Total Participants: 100
Study Start date:
April 19, 2021
Estimated Completion Date:
August 31, 2023

Study Description

After being informed about the study potential risks, all patients giving written informed consent will undergo screening to determine eligibility for study entry. They will be randomly assigned to two conditions (Imagery rescripting Vs. Imaginal exposure) at a 1:1 ratio. Participants will attend three ~1 hour online ZOOM sessions (pre-assessment and measurement, intervention, and post assessment and measurement).

Assessors will be blind to the treatment condition.

Connect with a study center

  • Hebrew University of Jerusalem

    Jerusalem, 9190501
    Israel

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.